Clinical Trials
Covid-19: Russia’s Sputnik V vaccine confirms 91.4% efficacy
Russia’s Sputnik V vaccine has demonstrated an efficacy of over 90 percent, according to the Gamaleya Center and the Russian Direct Investment Fund.
“Evaluation of efficacy...
Clinical Trials
Roche launches laboratory SARS-CoV-2 antigen test to support high-volume...
Roche announced that it has launched a high-throughput SARS-CoV-2 antigen test as an aid in the diagnosis of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)...
Clinical Trials
Sanofi, GSK COVID-19 vaccine rollout delayed on low immune...
Sanofi and GSK announce a delay in their adjuvanted recombinant protein-based COVID-19 vaccine program to improve immune response in older adults. Phase 1/2 study interim...
Clinical Trials
Incyte Announces Results of Phase 3 RUXCOVID Study of...
Incyte announced that the Phase 3 RUXCOVID study evaluating the safety and efficacy of ruxolitinib (Jakafi®), a JAK1/JAK2 inhibitor, plus standard-of-care (SoC) as a treatment...
Clinical Trials
Novartis provides update on RUXCOVID study of ruxolitinib for...
Novartis announced that the Phase III RUXCOVID study evaluating ruxolitinib on top of standard of care (SoC) therapy compared to SoC treatment alone in patients...
Clinical Trials
Sinovac snags $515M investment to double COVID-19 vaccine capacity...
As the various COVID-19 vaccines move closer to the finish line, their developers have been raising money from investors or through advance government purchases to...
Clinical Trials
Lilly’s tirzepatide significantly reduced A1C and body weight in...
Tirzepatide led to superior A1C and body weight reductions from baseline in adults with type 2 diabetes after 40 weeks of treatment in topline results...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.